Traders Purchase High Volume of Call Options on Waters (WAT) – Fairfield Current

This post was originally published on this site

Waters Co. (NYSE:WAT) saw some unusual options trading on Thursday. Stock traders purchased 885 call options on the stock. This is an increase of 1,305% compared to the typical volume of 63 call options.

NYSE:WAT opened at $229.30 on Friday. The company has a quick ratio of 2.01, a current ratio of 2.26 and a debt-to-equity ratio of 0.61. Waters has a 12 month low of $167.93 and a 12 month high of $233.48. The company has a market capitalization of $17.62 billion, a price-to-earnings ratio of 27.66, a P/E/G ratio of 2.30 and a beta of 1.17.

Waters (NYSE:WAT) last issued its quarterly earnings data on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.64 by $0.23. Waters had a net margin of 24.54% and a return on equity of 34.18%. The firm had revenue of $715.00 million during the quarter, compared to the consensus estimate of $702.74 million. During the same quarter in the previous year, the firm posted $2.51 EPS. The company’s revenue for the quarter was up 4.0% compared to the same quarter last year. On average, sell-side analysts forecast that Waters will post 9.35 earnings per share for the current year.

In other Waters news, SVP Elizabeth B. Rae sold 10,800 shares of the stock in a transaction on Tuesday, February 5th. The stock was sold at an average price of $232.35, for a total transaction of $2,509,380.00. Following the sale, the senior vice president now owns 8,794 shares in the company, valued at $2,043,285.90. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Christopher A. Kuebler sold 8,000 shares of the stock in a transaction on Friday, November 16th. The stock was sold at an average price of $199.67, for a total value of $1,597,360.00. Following the sale, the director now owns 18,911 shares in the company, valued at approximately $3,775,959.37. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 97,249 shares of company stock valued at $20,981,857. 0.98% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Athena Capital Advisors LLC purchased a new stake in Waters in the 4th quarter worth $28,000. Rockland Trust Co. bought a new position in Waters during the 4th quarter valued at about $38,000. Reilly Financial Advisors LLC grew its stake in Waters by 334.8% in the 4th quarter. Reilly Financial Advisors LLC now owns 200 shares of the medical instruments supplier’s stock worth $38,000 after acquiring an additional 154 shares in the last quarter. Lindbrook Capital LLC bought a new position in Waters in the 4th quarter worth about $41,000. Finally, Enlightenment Research LLC bought a new position in Waters in the 4th quarter worth about $57,000. Institutional investors own 92.30% of the company’s stock.

A number of research analysts have recently issued reports on WAT shares. Cleveland Research raised Waters from a “sell” rating to a “neutral” rating in a research note on Thursday, October 11th. JPMorgan Chase & Co. cut their target price on Waters from $200.00 to $185.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 24th. Barclays cut their target price on Waters from $200.00 to $190.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 24th. UBS Group cut their target price on Waters from $210.00 to $200.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 24th. Finally, ValuEngine upgraded shares of Waters from a “hold” rating to a “buy” rating in a report on Tuesday, November 27th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $208.99.

ILLEGAL ACTIVITY NOTICE: “Traders Purchase High Volume of Call Options on Waters (WAT)” was published by Fairfield Current and is owned by of Fairfield Current. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.fairfieldcurrent.com/news/2019/02/08/stock-traders-buy-large-volume-of-waters-call-options-wat.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: What does the Dow Jones Industrial Average (DJIA) measure?

Receive News & Ratings for Waters Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Waters and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply